Works by Seppänen, Marko


Results: 65
    1
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13

    Planar Scintigraphy with <sup>123</sup>I/<sup>99m</sup>Tc-Sestamibi, <sup>99m</sup>Tc-Sestamibi SPECT/CT, <sup>11</sup>C-Methionine PET/CT, or Selective Venous Sampling Before Reoperation of Primary Hyperparathyroidism?

    Published in:
    Journal of Nuclear Medicine, 2013, v. 54, n. 5, p. 739, doi. 10.2967/jnumed.112.109561
    By:
    • Schalin-Jäntti, Camilla;
    • Ryhänen, Eeva;
    • Heiskanen, Ilkka;
    • Seppänen, Marko;
    • Arola, Johanna;
    • Schildt, Jukka;
    • Väisänen, Mika;
    • Nelimarkka, Lassi;
    • Lisinen, Irina;
    • Aalto, Ville;
    • Nuutila, Pirjo;
    • Välimäki, Matti J.
    Publication type:
    Article
    14

    Complementary Roles of <sup>18</sup>F-DOPA PET/CT and <sup>18</sup>F-FDG PET/CT in Medullary Thyroid Cancer.

    Published in:
    Journal of Nuclear Medicine, 2011, v. 52, n. 12, p. 1855, doi. 10.2967/jnumed.111.094771
    By:
    • Kauhanen, Saila;
    • Schalin-Jäntti, Camilla;
    • Seppänen, Marko;
    • Kajander, Sami;
    • Virtanen, Sami;
    • Schildt, Jukka;
    • Lisinen, Irina;
    • Ahonen, Aapo;
    • Heiskanen, Ilkka;
    • Väisänen, Mika;
    • Arola, Johanna;
    • Korsoff, Pirkko;
    • Ebeling, Tapani;
    • Sane, Timo;
    • Minn, Heikki;
    • Välimäki, Matti J.;
    • Nuutila, Pirjo
    Publication type:
    Article
    15
    16
    17
    18
    19
    20
    21
    22

    <sup>18</sup>F-fluorodeoxyglucose-positron emission tomography/computed tomography after one cycle of chemotherapy in patients with diffuse large B-cell lymphoma: results of a Nordic/US intergroup study.

    Published in:
    Leukemia & Lymphoma, 2015, v. 56, n. 7, p. 2005, doi. 10.3109/10428194.2014.975800
    By:
    • Mylam, Karen Juul;
    • Kostakoglu, Lale;
    • Hutchings, Martin;
    • Coleman, Morton;
    • Lamonica, Dominick;
    • Czuczman, Myron S.;
    • Diehl, Louis F.;
    • Nielsen, Anne L.;
    • Jensen, Paw;
    • Loft, Annika;
    • Hendel, Helle W.;
    • Iyer, Victor;
    • Leppä, Sirpa;
    • Jyrkkiö, Sirkku;
    • Holte, Harald;
    • Eriksson, Mikael;
    • Gillstrøm, Dorte;
    • Hansen, Per B.;
    • Seppänen, Marko;
    • Hjorthaug, Karin
    Publication type:
    Article
    23
    24
    25
    26

    Prospective comparison of 18F-PSMA-1007 PET/CT, whole-body MRI and CT in primary nodal staging of unfavourable intermediate- and high-risk prostate cancer.

    Published in:
    European Journal of Nuclear Medicine & Molecular Imaging, 2021, v. 48, n. 9, p. 2951, doi. 10.1007/s00259-021-05296-1
    By:
    • Malaspina, Simona;
    • Anttinen, Mikael;
    • Taimen, Pekka;
    • Jambor, Ivan;
    • Sandell, Minna;
    • Rinta-Kiikka, Irina;
    • Kajander, Sami;
    • Schildt, Jukka;
    • Saukko, Ekaterina;
    • Noponen, Tommi;
    • Saunavaara, Jani;
    • Dean, Peter B.;
    • Sequeiros, Roberto Blanco;
    • Aronen, Hannu J.;
    • Kemppainen, Jukka;
    • Seppänen, Marko;
    • Boström, Peter J.;
    • Ettala, Otto
    Publication type:
    Article
    27
    28
    29
    30
    31

    Correlation of F-FDG PET/CT assessments with disease activity and markers of inflammation in patients with early rheumatoid arthritis following the initiation of combination therapy with triple oral antirheumatic drugs.

    Published in:
    European Journal of Nuclear Medicine & Molecular Imaging, 2013, v. 40, n. 3, p. 403, doi. 10.1007/s00259-012-2282-x
    By:
    • Roivainen, Anne;
    • Hautaniemi, Sannamari;
    • Möttönen, Timo;
    • Nuutila, Pirjo;
    • Oikonen, Vesa;
    • Parkkola, Riitta;
    • Pricop, Luminita;
    • Ress, Rudyard;
    • Seneca, Nicholas;
    • Seppänen, Marko;
    • Yli-Kerttula, Timo
    Publication type:
    Article
    32
    33
    34
    35
    36
    37

    The risk of exaggerated risk aversion--a life and death struggle for molecular imaging.

    Published in:
    European Journal of Nuclear Medicine & Molecular Imaging, 2009, v. 36, n. 10, p. 1693, doi. 10.1007/s00259-009-1190-1
    By:
    • Långström, Bengt;
    • Grahnen, Anders;
    • Honoré, Per Hartvig;
    • Borlak, Jürgen;
    • Bergstrom, Mats;
    • Nielsen, Bengt;
    • Vanderheyden, JeanLuc;
    • Watanabe, Yasuyoshi;
    • Josephsson, Raymond;
    • Høilund-Carlsen, Poul F.;
    • Schwaiger, Markus;
    • Larson, Steven M.;
    • Goldenberg, David M.;
    • Melzer, Andreas;
    • Engler, Henry;
    • Hicks, Rodney;
    • Sundin, Anders;
    • Seppänen, Marko;
    • Hedenstierna, Göran;
    • Nordberg, Agneta
    Publication type:
    Article
    38
    39
    40
    41
    42
    43
    44
    45
    46
    47

    Response to Letter on use of functional imaging by <sup>11</sup>C-metomidate PET for primary aldosteronism subtyping.

    Published in:
    European Journal of Endocrinology, 2021, v. 184, n. 3, p. L11, doi. 10.1530/EJE-21-0048
    By:
    • Soinio, Minna;
    • Luukkonen, Anna-Kaarina;
    • Seppänen, Marko;
    • Kemppainen, Jukka;
    • Seppänen, Janne;
    • Pienimäki, Juha-Pekka;
    • Leijon, Helena;
    • Vesterinen, Tiina;
    • Arola, Johanna;
    • Lantto, Eila;
    • Helin, Semi;
    • Tikkanen, Ilkka;
    • Metso, Saara;
    • Mirtti, Tuomas;
    • Heiskanen, Ilkka;
    • Norvio, Leena;
    • Tiikkainen, Mirja;
    • Tikkanen, Tuula;
    • Sane, Timo;
    • Välimäki, Matti
    Publication type:
    Article
    48

    Functional imaging with 11C-metomidate PET for subtype diagnosis in primary aldosteronism.

    Published in:
    European Journal of Endocrinology, 2020, v. 183, n. 6, p. 539, doi. 10.1530/EJE-20-0532
    By:
    • Soinio, Minna;
    • Luukkonen, Anna-Kaarina;
    • Seppänen, Marko;
    • Kemppainen, Jukka;
    • Seppänen, Janne;
    • Pienimäki, Juha-Pekka;
    • Leijon, Helena;
    • Vesterinen, Tiina;
    • Arola, Johanna;
    • Lantto, Eila;
    • Helin, Semi;
    • Tikkanen, Ilkka;
    • Metso, Saara;
    • Mirtti, Tuomas;
    • Heiskanen, Ilkka;
    • Norvio, Leena;
    • Tiikkainen, Mirja;
    • Tikkanen, Tuula;
    • Sane, Timo;
    • Välimäki, Matti
    Publication type:
    Article
    49
    50